We are live on ! Find out more
ELGX

Endologix Inc
ELGX

Delisted

ELGX was delisted on the 15th of July, 2020.

135 hedge funds and large institutions have $1.01B invested in Endologix Inc in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $824M → $1.01B (+$185M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

1% less funds holding

Funds holding: 136135 (-1)

13% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 55

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $21K

Holders
135
Holders Change
-1
Holders Change %
-0.74%
% of All Funds
4.36%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
48
Reduced
55
Closed
11
Calls
Puts
$21K
Net Calls
-$21K
Net Calls Change
-$18K

ELGX Hedge Fund Activity: Q3 2013 in Review

135 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q3 2013, worth a combined $1.01B — up 22% from $824M a quarter earlier.

Fund positioning in ELGX was balanced in Q3 2013: 11 funds opened new positions, 11 closed out, 48 added to existing stakes and 55 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $22.5M. The largest seller was Wells Fargo, cutting an estimated $12.4M.

  • 135 institutional investors held Endologix Inc (ELGX) as of Q3 2013, down from 136 in Q2 2013.
  • Funds reported $1.01B of Endologix Inc stock for Q3 2013, up 22% quarter-over-quarter.
  • 11 funds opened new Endologix Inc positions in Q3 2013 and 11 closed out, a net change of 0 holders.
  • The largest Endologix Inc buyer in Q3 2013 was Lord, Abbett & Co, an estimated $22.5M added.
  • The largest Endologix Inc seller in Q3 2013 was Wells Fargo, an estimated $12.4M sold.

Based on aggregated 13F filings for Q3 2013.